Tweets from web

Aberman: From a business to an asset: VCs is all about the money, a different world #BHCRForum18

2:10pm April 23rd 2018 via Twitter Web Client

Aberman: There is other monies where rate of return. For a company: you have to be liked #BHCRForum18 Justifying the decision

2:03pm April 23rd 2018 via Twitter Web Client

Aberman: You need advisors to help to be there for them #BHCRForum18 Investing money: no worries about internal rate of return

2:01pm April 23rd 2018 via Twitter Web Client

Galvin: Bias: what needs a VC has (ex: 3y vs a 7y horizon) #BHCRForum18 His funding came from high net-worth individuals 'had the vision'

2:00pm April 23rd 2018 via Twitter Web Client

Silber: Can readily identify areas of blind-spots. Galvin: Gets great feedback from VCs that turn him down #BHCRForum18 What to be aware of

1:58pm April 23rd 2018 via Twitter Web Client

Young: And many times that comes from your investor - they've done this before. Klein: Why they called it Courage #BHCRForum18

1:55pm April 23rd 2018 via Twitter Web Client

Young: W/o a mentor, 'life is much more difficult'. (Well said!) #BHCRForum18

1:55pm April 23rd 2018 via Twitter Web Client

Young: Everyone in business needs mentoring. Usually people a little older, and survived mistakes. #BHCRForum18

1:54pm April 23rd 2018 via Twitter Web Client

Aberman: "That's what's so great about angel investing: it's such a human endeavor" #BHCRForum18 Q: what makes someone good?

1:54pm April 23rd 2018 via Twitter Web Client

Galvin: "If I had a nickel..." #BHCRForum18 investment is in people; if the idea is sound, it's the people that will make-or-break

1:52pm April 23rd 2018 via Twitter Web Client

Silber: Pointed out when a deal isn't all that great; successful angels often are part of syndicates, groups #BHCRForum18

1:50pm April 23rd 2018 via Twitter Web Client

Silber: "If I was dating on my own, I'd be far more impulsive" - thus helping to avoid poor decisions #BHCRForum18

1:49pm April 23rd 2018 via Twitter Web Client

Klein: Dating analogy "you do develop a methodology"; wasted time, a migration to a process #BHCRForum18

1:49pm April 23rd 2018 via Twitter Web Client

Aberman: Rich people can be sophisticated or just an investor; it is 'their money'- how much is it like dating? (!!) #BHCRForum18

1:48pm April 23rd 2018 via Twitter Web Client

Galvin: Your value and integrity will be communicated out. Aberman: angels are wealthy. >$1 M networth, high income etc. #BHCRForum18

1:47pm April 23rd 2018 via Twitter Web Client

Klein: Dollar amts also all over the map: $10K to $ millions - 'it's my money'. Retired people - a personal decision #BHCRForum18

1:44pm April 23rd 2018 via Twitter Web Client

Galvin: Now growing a gene Rx co, making a difference https://t.co/Ebve9wx3aN Not an expert: now like mini-VC's, same habits #BHCRForum18

1:42pm April 23rd 2018 via Twitter Web Client

Silber: 90-98% do not continue on the initial path; to get into the competitive world of unknown unknowns #BHCRForum18

1:39pm April 23rd 2018 via Twitter Web Client

Silber: Both entrepreneurs and capitalistic: developing trust and longstanding rel's, to support growth, success #BHCRForum18

1:38pm April 23rd 2018 via Twitter Web Client

Klein: Growing teams, sees tech CEOs grow from defending to creating something #BHCRForum18

1:37pm April 23rd 2018 via Twitter Web Client

Young: 'Nobody else knows the answer either' - actively involved in helping. Galvin: Spending time 'evangelizing our mission' #BHCRForum18

1:36pm April 23rd 2018 via Twitter Web Client

Forum: Angel Investors: Where are they? What do they want? How do I acces them? #BHCRForum18 Jon Aberman (MD Amplifier Ventures)

1:32pm April 23rd 2018 via Twitter Web Client

Q: Interoperable EHR? Single-payer country better? #BHCRForum18 Jain: Ease of access w/1 system. But case-dep: how open is the country?

12:24pm April 23rd 2018 via Twitter Web Client

(Long comment on defining reproducibility) #BHCRForum18 Madhavan: FAIR principles (NB slideshare https://t.co/DHQ4FD7f3r )

12:21pm April 23rd 2018 via Twitter Web Client

Comment / Q regarding 'the right variables to use' Madhavan: #BHCRForum18 What predicts longevity in the US? Credit score.

12:12pm April 23rd 2018 via Twitter Web Client

Jain: #BHCRForum18 to bring a PhD, an MD, and a business-person in the same room, and bring it to the public? SW, HW, Devices...

12:06pm April 23rd 2018 via Twitter Web Client

Q: Given Oculus' donation, how is UMD positioned? #BHCRForum18 Varshney: The big data problem can be helped by AR/VR

11:50am April 23rd 2018 via Twitter Web Client

Madhavan: #BHCRForum18 Perthera has a recommender database platform for personalized medicine.

11:49am April 23rd 2018 via Twitter Web Client

Madhavan: (con't) ID'd a ROS1 fusion, enrolled into trial, 7mos in still 'doing well' IGNYTA trial #BHCRForum18 https://t.co/obhw5WeLa5

11:47am April 23rd 2018 via Twitter Web Client

Madhavan: Using datascience to help metastatic cancer. #BHCRForum18 Story: 51yo male almost headed to hospice. Genomics, proteomics

11:45am April 23rd 2018 via Twitter Web Client

Q: Opioid crisis - how can devices help? #BHCRForum18 Gura: decades ago at MDAnderson vs now. Proper Dx, Rx for pain.

11:43am April 23rd 2018 via Twitter Web Client

Bentley: #BHCRForum18 Starts with his new institute for biomedical devices at UMD: molecular info into devices

11:40am April 23rd 2018 via Twitter Web Client

Emerging regional clusters: Digital Health, Devices and Augmented Reality #BHCRForum18 Bill Bentley (UMD, Inst for Biomed Devices)...

11:37am April 23rd 2018 via Twitter Web Client

Q: Other things that SBIR can help make it easier? #BHCRForum18 Lynn: "we did apply - unsuccessfully - for SBIR"

11:02am April 23rd 2018 via Twitter Web Client

Q: 90% of deals fall apart in due diligence. #BHCRForum18 Dudek: IP is an impt fn of process. One pass may become another company

11:01am April 23rd 2018 via Twitter Web Client

Q: Top regions have interactions w/clinicians? How to optimize? #BHCRForum18 Davile: They come naturally, w/pts who have no options

10:59am April 23rd 2018 via Twitter Web Client

Q: Protection of IP in China? #BHCRForum18 Davile: Was told 'not to bother with China' as their filing was copied - verbatim.

10:55am April 23rd 2018 via Twitter Web Client

Dudek: #BHCRForum18 Gives background on Miltenyi, dedicated German dev group. Vibrant area. Davile: Some history abt Rosenberg's NCI work

10:46am April 23rd 2018 via Twitter Web Client

Wyskiel: Post-acquisition? Dudek: #BHCRForum18 Busy at Lentigen, getting ready for clinical study design, prog mgmt on platform

10:43am April 23rd 2018 via Twitter Web Client

Wyskiel (host): How was the $3M raise process? #BHCRForum18 Lynn: Had a platform, a multi-year process. Wyskiel: Know your audience

10:42am April 23rd 2018 via Twitter Web Client

Ishizuka: Licensing out of 3 NIH institutes: once you ID the right person, 'incredibly helpful'. Est of CRADA #BHCRForum18

10:36am April 23rd 2018 via Twitter Web Client

Davile: Collab impt, connections too; also close to the clinical applicability. #BHCRForum18

10:34am April 23rd 2018 via Twitter Web Client